In vivo studies using an axotomy model in adult male Naval Medical Research Institute mice. Objective: Survivin, a unique member of the inhibitor of the apoptosis (IAP) protein family, is expressed during embryonal development, but is undetectable in terminally differentiated cells and tissues. Owing to the vital role of survivin in cellular proliferation and apoptotic cell death, and also to the necessity of treatment of the nervous system injuries, we have monitored survivin gene expression as well as its alternative splicing changes at different time points within injured mouse sciatic nerves. Setting: Department of Genetics, School of Basic Sciences, Tarbiat Modares University, Tehran, Iran. Methods: The sciatic nerves of adult male Naval Medical Research Institute mice were transected and the expression of survivin was examined in the distal and proximal parts of the dissected nerves as well as in the corresponding segments within the spinal cord of the animals, using semi-quantitative RT-PCR and immunohistochemistry. Results: Survivin is not expressed in undamaged sciatic nerves, but, after sciatic nerve injury, it is gradually upregulated in proximal and distal parts of the dissected nerve (Po0.05). Survivin140 is the main variant expressed after injury, accompanied by a low expression of survivin40 (Po0.05). There was no expression of the survivin121 variant after injury. Conclusions: Survivin is differentially expressed and spliced in damaged nerve and spinal cord. Future works on the manipulation of expression and/or the splicing of survivin could decipher the potential effects of survivin variants on the regeneration of nerve and/or spinal cord injuries.
Introduction
During mammalian development, almost half of the initially overproduced neurons are eliminated by apoptosis to define the optimal number of neurons required for normal nervous system function. 1 Deregulation of the balance between cell division and apoptosis results in either tumors or neurodegenerative diseases. Survivin, a member of the inhibitor of the apoptosis (IAP) family of proteins, 2 is known to be involved in both regulation of apoptosis and control of cell division. [3] [4] [5] Survivin is highly expressed during normal tissue development, 6, 7 including the nervous system, 7 but it is absent in most terminally differentiated cells of adult tissue. 7, 8 This suggests an important role for this protein in cell division.
Within the human brain, survivin is expressed in regions populated by neural progenitor cells. 9 Recent identification of several functionally divergent survivin variants in mouse and human has shown the complexity of survivin action as well as its regulation. The mouse survivin gene has four exons and produces at least three proteins with distinct physiological functions. 10 The largest one, survivin140, is composed of all four exons. This variant contains a single IAP domain and a conserved coiledcoil domain. The IAP domain is found to be antiapoptotic; in a way, it links the biological function of the protein to the cell cycle. The other variant, survivin121, lacks exon 4 and the coiled-coil domain, but retains a part of intron 3. The third variant, survivin40, lacks both IAP and coiled-coil domains and contains only exons 1 and 3, and most likely, it loses its antiapoptotic activity. 10 Different levels of expression for all three variants have been reported during mouse embryonic development. 10, 11 Furthermore, the cellular functions of survivin can differ depending on the cell type (for example, tumoral vs nontumoral cells). 4 Owing to the vital role of survivin in cellular proliferation and apoptotic cell death, we have evaluated the alterations in survivin gene expression and its alternative splicing in sciatic nerve injury using a semi-quantitative RT-PCR technique.
Materials and methods
Animal surgery A total of 24 adult male outbred white Naval Medical Research Institute mice (8-10 weeks old) were obtained from the Razi Institute (Karaj, Iran). For transection of sciatic nerve, the animals were anesthetized with a mixture of xylazine and ketamine (80-100 mg kg À1 ketamine þ 10 mg kg À1 xylazine, i.p.). Briefly, a 3 mm segment of the right-side sciatic nerve was removed by a sharp cut and the distal and proximal stumps of the sciatic nerve were diverted into adjacent muscles to minimize the regrowth of fibers.
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The apparent health and behaviors of the animals were monitored routinely. At specific time points after the axotomy, the animals were killed by cervical dislocation, and both distal and proximal segments (5 mm of each) of the transected sciatic nerve, intact left sciatic nerve and the lumbosacral part of the spinal cord (L4-L6 segments) were taken for gene expression analysis.
RNA extraction
Total RNA was extracted from frozen tissues using the RNX plus solution (Cinnagen, Tehran, Iran) with some changes to the manufacturer's instructions for a small amount of tissue. Briefly, after homogenizing the tissue, 800 ml of RNX solution and 160 ml of chloroform (Merck kGaA, Darmstadf, Germany) were added to the solution and centrifuged for 15 min at 12 000 g at 4 1C. The upper phase was then transferred into another tube and RNA was precipitated with 0.4 ml of isopropanol (Merck) for at least 45 min at 4 1C. The mixture was centrifuged for 15 min at 12 000 g, at 4 1C. The resulting pellet was then washed in 75% ethanol and dissolved in diethylpyrocarbonate (DEPC)-treated water.
RT-PCR reaction
Complementary DNA (cDNA) synthesis was carried out using 1 mg RNA and MMLV reverse transcriptase with oligo(dT) 18 (Fermentas, York, UK) priming in a 20 ml reaction. Specific primers for mouse survivin and b-2 microglobulin (b2m; GenBank accession number: AF115517 and NM-009735, respectively) were used as described earlier.
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The sequences of the primers used were as follows: Quantification of the intensity of PCR products PCR products were separated on a 1% agarose gel and visualized by ethidium bromide staining. The amount of DNA was quantified by measuring the intensity of light emitted from corresponding bands under UV light using Labimage software (version 2.6; Kapelan GmbH Co., Halle, Germany).
The results were expressed as the ratio of the intensity of the survivin gene band to that of b2m as an internal control, 11 wherein the comparisons were made for matched internal controls.
Statistical analysis
All experiments were replicated at least thrice and the results were analyzed by performing analysis of variance (ANOVA) followed by Tukey tests, with Po0.05 considered as statistically significant. The s.d. was also calculated for each value.
Immunohistochemistry
Tissue samples from four injured and one un-injured mice were collected. 5 mm tissue sections were deparaffinized in xylene and rehydrated by passing through graded alcohols. For antigen retrieval, slides were placed in a water bath with 9 mM sodium citrate, pH 
Results

RT-PCR optimization
RT-PCR reactions were optimized by varying the number of amplification cycles, in increments of two cycles, starting
Survivin expression in injured mouse sciatic nerves S Amiri et al from 20 to 40 cycles, to select the lowest cycle number in which transcripts could be quantified without reaching the stationary phase. The band intensity increased almost linearly as the reaction approached the stationary phase. An amplified band corresponding to the expected size for the b2m gene appeared at cycle 26 for spinal cord and at cycle 30 for sciatic nerve samples (data not shown). The same procedure was used for the amplification of survivin, and the cycle number of 35 was used for all PCR reactions (data not shown).
The size of the amplified DNA fragment for both survivin140 (254 bp) and survivin40 (144 bp) was as expected for both variants (Figure 1 ). To further confirm the accuracy of the PCR products, the amplified survivin and b2m products were digested with an EcoRI restriction enzyme. This generated two smaller fragments for both survivin140 (242 þ 12 bp) and survivin40 (132 þ 12 bp) variants, as well as two smaller fragments for b2m (222 þ 94 bp). These sizes were, as expected, based on the calculated products from the primary sequences of survivin and b2m (data not shown).
Changes in the expression of survivin variants after nerve injury Four different tissue samples were collected and analyzed as the following: distal and proximal segments of transected sciatic nerve, intact sciatic nerve on the other side (as control), and L4-L6 segments of the spinal cord (L4-L6 segments of un-injured animal used as a control).
The gene expression levels were examined for survivin variants using a semi-quantitative RT-PCR technique. To ensure that equal amounts of RNA were used for each reaction and that differences in the signal intensity were not because of the differences in the amounts of starting RNA, b2m was used as an internal control for each amplification reaction. RT-PCR was carried out in separate tubes under similar conditions (except for the cycle number) for both survivin and b2m with results expressed as survivin/b2m expression ratio. All experiments were repeated at least thrice, and the amplified products were loaded onto agarose gel and electrophoresed. As expected, b2m was expressed in all specimens. The PCR for survivin produced two DNA segments of 254 and 144 bp in specimens obtained from distal ( Figure 1a ) and proximal (Figure 1b) segments of dissected sciatic nerve, and only a 254 bp single band in the spinal cord (Figure 1c ).
There was a significant variation in the level of expression, both in different variants as well as in different samples, obtained from the sciatic nerve and the spinal cord. Both survivin140 and survivin40 were absent in undamaged sciatic nerve, but they were gradually expressed in distal and proximal segments of the sciatic nerve with different intensity, in which survivin140 was the prominent variant (Figures 1 and 2) . In spinal cord segments, there was no detectable expression of survivin40. However, the expression of survivin140 was evident in the spinal cord of both the control and nerve injury model (Figures 1c and 2e) . There Survivin expression in injured mouse sciatic nerves S Amiri et al was no detection of survivin121 variant in the proximal and distal segments of the sciatic nerve or in their corresponding segments in the spinal cord. The mean for the relative expression of survivin variants was normalized to the expression of b2m and the significance of the differences was tested by ANOVA ( Figure 2 ).
Immunohistochemistry of survivin protein
To determine the cellular expression of survivin at the protein level, we used the immunohistochemistry technique using a specific antibody against survivin, which detects all variants of survivin. After optimization of the method, the expression of the survivin protein was evaluated on the sciatic nerve segments and on the L4-L6 segments of the spinal cord after 6 days (144 h) of axotomy. The results showed both nuclear and cytoplasmic distribution of the survivin protein in the spinal cord (Figure 3a) , but there was a very weak or no signal of survivin in either distal or proximal segments of the sciatic nerve (Figure 3c ). The immunoreactivity was seemingly distributed within both dorsal and ventral horns but not within the white matter. There was also no noticeable difference between the signal strength of survivin between damaged and un-damaged samples. There was no signal in the control sections in which all the conditions were maintained the same, except for omission of the first antibody (Figures 3b, d) .
Discussion
A hallmark of many neurodegenerative diseases is neuronal cell death. 13 In apoptotic cell death, neurons are actively 
responsible for their own death by switching on/off a number of cell-death regulatory genes or intracellular pathways. 1, 14 Given that the central nervous system has very limited regenerative capacity, it is of utmost importance to limit the damage caused by neuronal death. 15 As a member of the IAP family, survivin plays a crucial role in both cell proliferation and apoptosis. 8 Furthermore, alternatively spliced variants of the gene seem to have their own unique subcellular localizations and (sometimes opposing) functions. 10 Although the overexpression of survivin is widely studied in various tumors, including glioblastomas, meningiomas, schwannomas and neurofibromas, 16 very little attention has been given so far to its expression profile in neurodegenerative disorders. Here, we have evaluated the alterations in the expression of different variants of survivin after axotomy of the mouse sciatic nerve. Our data indicate a differential expression of survivin variants in the proximal and distal parts of the dissected nerve as well as in their corresponding neuronal cell bodies located within L4-L6 segments of the spinal cord. Our data showed for the first time that (1) there is no detectable expression of survivin variants in undamaged sciatic nerve, whereas there is some expression in the spinal cord. (2) Both survivin140 and survivin40 variants are absent in the sciatic nerve, but they are gradually overexpressed in the proximal and distal parts of the damaged nerve, where they reach their peak of expression, within proximal segments, 2 days after the damage. This observation is consistent with earlier works in which significant gene/ protein expression alterations were reported 3 days after axonal injury. 17, 18 A possibility for such a delay in reaching the peak of gene expression alterations might be the induction of glial cells (for example, Schwann cells) and macrophage proliferation 2 days after postaxotomy. 19 These proliferative cells could be the cause for the the observed overexpression of survivin after nerve injury. The notion that there is no survivin140 expression in undamaged sciatic nerve and that there is no expression of survivin40 in undamaged and damaged spinal cord could be eluding to the differential expression and alternative splicing of survivin within the central and peripheral nervous system. The difference is probably established through different microenvironments and/or different cell type compositions of the spinal cord and sciatic nerve. In other words, the survivin variants could have different roles within the damaged nerve. To find out whether the overexpression of the survivin variants has a causative effect in the process of regeneration, or whether it is simply a byproduct of the global changes on the damaged nerves, would require further investigation. Performing the same experiment on a transgenic mouse model in which the expression of survivin is knocked out in neuronal 15 Furthermore, the expression was also studied after traumatic brain injury by Johnson et al. 20 On the basis of their report, the expression of survivin was time dependent and cell specific, and was present in astrocytes and, to a much lesser extent, in neurons of brain cortex and hippocampus. Induction of survivin in these cells was accompanied by occasional expression of PCNA, a cell cycle protein involved in mitotic G1/S progression. 20 Our presented data, along with earlier findings, provide a clearer picture on the involvement of survivin in normal and abnormal physiology of the nervous system.
Conclusion
In conclusion, our data suggest that survivin is differentially expressed and spliced after nerve injury. However, more work is needed to elucidate the complex role of survivin variants in neuronal and glial cells.
